Correlation Between Virpax Pharmaceuticals and Pasithea Therapeutics
Can any of the company-specific risk be diversified away by investing in both Virpax Pharmaceuticals and Pasithea Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virpax Pharmaceuticals and Pasithea Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virpax Pharmaceuticals and Pasithea Therapeutics Corp, you can compare the effects of market volatilities on Virpax Pharmaceuticals and Pasithea Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virpax Pharmaceuticals with a short position of Pasithea Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virpax Pharmaceuticals and Pasithea Therapeutics.
Diversification Opportunities for Virpax Pharmaceuticals and Pasithea Therapeutics
0.14 | Correlation Coefficient |
Average diversification
The 3 months correlation between Virpax and Pasithea is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Virpax Pharmaceuticals and Pasithea Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pasithea Therapeutics and Virpax Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virpax Pharmaceuticals are associated (or correlated) with Pasithea Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pasithea Therapeutics has no effect on the direction of Virpax Pharmaceuticals i.e., Virpax Pharmaceuticals and Pasithea Therapeutics go up and down completely randomly.
Pair Corralation between Virpax Pharmaceuticals and Pasithea Therapeutics
Given the investment horizon of 90 days Virpax Pharmaceuticals is expected to under-perform the Pasithea Therapeutics. In addition to that, Virpax Pharmaceuticals is 1.9 times more volatile than Pasithea Therapeutics Corp. It trades about -0.29 of its total potential returns per unit of risk. Pasithea Therapeutics Corp is currently generating about -0.26 per unit of volatility. If you would invest 380.00 in Pasithea Therapeutics Corp on September 1, 2024 and sell it today you would lose (71.00) from holding Pasithea Therapeutics Corp or give up 18.68% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Virpax Pharmaceuticals vs. Pasithea Therapeutics Corp
Performance |
| Timeline |
| Virpax Pharmaceuticals |
| Pasithea Therapeutics |
Virpax Pharmaceuticals and Pasithea Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Virpax Pharmaceuticals and Pasithea Therapeutics
The main advantage of trading using opposite Virpax Pharmaceuticals and Pasithea Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virpax Pharmaceuticals position performs unexpectedly, Pasithea Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pasithea Therapeutics will offset losses from the drop in Pasithea Therapeutics' long position.| Virpax Pharmaceuticals vs. Revelation Biosciences | Virpax Pharmaceuticals vs. Palisade Bio | Virpax Pharmaceuticals vs. Virax Biolabs Group | Virpax Pharmaceuticals vs. Quoin Pharmaceuticals Ltd |
| Pasithea Therapeutics vs. Nutriband Warrant | Pasithea Therapeutics vs. MediciNova | Pasithea Therapeutics vs. Eliem Therapeutics | Pasithea Therapeutics vs. Virax Biolabs Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Complementary Tools
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |